An elastase-dependent attenuated heterologous swine influenza virus protects against pandemic H1N1 2009 influenza challenge in swine

Vaccine

Volumn 29, Issue 17, 2011, Pages 3118-3123

  Babiuk, Shawn ^a,b   Masic, Aleksandar ^c   Graham, Jill ^a   Neufeld, James ^a   van der Loop, Melanie ^a   Copps, John ^a   Berhane, Yohannes ^a   Pasick, John ^a   Potter, Andy ^c   Babiuk, Lorne A ^d   Weingartl, Hana ^a,b   Zhou, Yan ^c  

^a CANADIAN FOOD INSPECTION AGENCY   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

^c UNIVERSITY OF SASKATCHEWAN   (Canada)

^d UNIVERSITY OF ALBERTA   (Canada)

Author keywords

H1N1; Influenza; Neutralizing antibodies; Swine influenza; Vaccine

Indexed keywords

CROSS REACTING ANTIBODY; ELASTASE; ELASTASE DEPENDENT ATTENUATED HETEROLOGOUS SWINE INFLUENZA VACCINE; LIVE VACCINE; NEUTRALIZING ANTIBODY; SWINE INFLUENZA VACCINE; UNCLASSIFIED DRUG; VIRUS ANTIBODY; VIRUS NUCLEOPROTEIN; VIRUS RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY DETECTION; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; DRUG SCREENING; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; INFLUENZA VIRUS A H1N1; LUNG ALVEOLUS MACROPHAGE; LUNG HOMOGENATE; LUNG LOBE; NONHUMAN; NOSE SMEAR; PANDEMIC INFLUENZA; PRIORITY JOURNAL; PROVOCATION TEST; REAL TIME POLYMERASE CHAIN REACTION; SWINE; SWINE INFLUENZA; SWINE INFLUENZA VIRUS; VACCINATION; VIRUS DETECTION; VIRUS GENOME; VIRUS LOAD; VIRUS MUTANT; VIRUS NEUTRALIZATION; VIRUS SHEDDING;

ADMINISTRATION, INHALATION; ADMINISTRATION, INTRANASAL; ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; CROSS PROTECTION; CROSS REACTIONS; HUMANS; INFLUENZA A VIRUS; INFLUENZA VACCINES; LUNG; NASAL CAVITY; ORTHOMYXOVIRIDAE INFECTIONS; SWINE; SWINE DISEASES; VIRAL LOAD;

EID: 79954603126     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.02.069     Document Type: Article

References (27)

1. Shope R.E. Swine influenza. Filtration experiments and etiology. J Exp Med 1931, 54:373-385.
2. Gorman O.T., Bean W.J., Kawaoka Y., Donatelli I., Guo I.Y., Webster R.G. Evolution of influenza A virus nucleoprotein genes: implications for the origin of H1N1 human and classical swine viruses. J Virol 1991, 65:3704-3714.
3. Taubenberger J.K., Reid A.H., Lourens R.M., Wanf R., Jim G., Fanning T.G. Characterization of the 1918 influenza virus polymerase genes. Nature 2005, 437:889-893.
4. Zhou N.N., Senne D.A., Landgraf J.S., Swenson S.L., Erickson G., Rossow K., et al. Genetic assortment of avian, swine, and human influenza A viruses in American pigs. J Virol 1999, 73:8851-8856.
5. Karasin A.I., Landgraf J., Swenson S., Erickson G., Goyal S., Woodruff M., et al. Genetic characterization of H1N2 influenza A viruses isolated from pigs throughout the United States. J Clin Microbiol 2002, 40:1073-1079.
6. Garten R.J., Davis C.T., Russell C.A., Shu B., Lindstrom S., Balish A., et al. Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science 2009, 325:197-201.
7. Lange E., Kalthoff D., Blohm U., Teifke J.P., Breithaupt A., Maresch C., et al. Pathogenesis and transmission of the novel swine-origin influenza virus A/H1N1 after experimental infection of pigs. J Gen Virol 2009, 90:2119-2123.
8. Mathieu C., Moreno V., Retamal P., Gonzalez A., Rivera A., Fuller J., et al. Pandemic (H1N1) 2009 in breeding turkeys, Valparaiso, Chile. Emerg Infect Dis 2010, 16:709-711.
9. Howden K.J., Brockhoff E.J., Caya F.D., McLeod L.J., Lavoie M., Ing J.D., et al. An investigation into human pandemic influenza virus (H1N1) 2009 on an Alberta swine farm. Can Vet J 2009, 50:1153-1161.
10. Weingartl H.M., Berhane Y., Hisanaga T., Neufeld J., Kehler H., Emburry-Hyatt C., et al. Genetic and pathobiologic characterization of pandemic H1N1 2009 influenza viruses from a naturally infected swine herd. J Virol 2010, 84:2245-2256.
11. Centers for Disease Control and Prevention (CDC) Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine. Morb Mortal Wkly Rep 2009, 58:521-524.
12. Vincent A.L., Ciacci-Zanella J.R., Lorusso A., Gauger P.C., Zanella E.L., Kehrli M.E., et al. Efficacy of inactivated swine influenza virus vaccines against the 2009 A/H1N1 influenza virus in pigs. Vaccine 2010, 28:2782-2787.
13. Masic A., Babiuk L.A., Zhou Y. Reverse genetics-generated elastase-dependent swine influenza viruses are attenuated in pigs. J Gen Virol 2009, 90:375-385.
14. Masic A., Booth J.S., Mutwiri G.K., Babiuk L.A., Zhou Y. Elastase-dependent live attenuated swine influenza A viruses are immunogenic and confer protection against swine influenza A infection in pigs. J Virol 2009, 83:10198-10210.
15. Masic A., Lu X., Li J., Mutwiri G.K., Babiuk L.A., Brown E.G., et al. Immunogenicity and protective efficacy of an elastase-dependent live attenuated swine influenza virus vaccine administered intranasally in pigs. Vaccine 2010, 28:7098-7108.
16. Karasin A.I., West K., Carman S., Olsen C.W. Characterization of avian H3N3 and H1N1 influenza A viruses isolated from pigs in Canada. J Clin Microbiol 2004, 42:4349-4354.
17. Spackman E., Senne D.A., Myers T.J., Bulaga L.L., Garber L.P., Perdue M.L., et al. Development of a real-time reverse transcriptase PCR assay for type A influenza virus and avian H5 and H7 hemagglutinin subtypes. J Clin Microbiol 2002, 40:3256-3260.
18. Babiuk S., Albrecht R., Berhane Y., Marszal P., Richt J.A., García-Sastre A., et al. 1918 and 2009 H1N1 influenza viruses are not pathogenic in birds. J Gen Virol 2010, 91:339-342.
19. Weingartl H.M., Albrecht R.A., Lager K.M., Babiuk S., Marszal P., Neufeld J., et al. Experimental infection of pigs with the human 1918 pandemic influenza virus. J Virol 2009, 83:4287-4296.
20. Zhou E.M., Chan M., Heckert R.A., Riva J., Cantin M.F. Evaluation of a competitive ELISA for detection of antibodies against avian influenza virus nucleoprotein. Avian Dis 1998, 42:517-522.
21. Heinen P.P., de Boer-Luijtze E.A., Bianchi A.T. Respiratory and systemic humoral and cellular immune responses of pigs to a heterosubtypic influenza A virus infection. J Gen Virol 2001, 82:2697-2707.
22. Van Reeth K., Gregory V., Hay A., Pensaert M. Protection against a European H1N2 swine influenza virus in pigs previously infected with H1N1 and/or H3N2 subtypes. Vaccine 2003, 21:1375-1381.
23. Vincent A.L., Ma W., Lager K.M., Janke B.H., Webby R.J., García-Sastre A., et al. Efficacy of intranasal administration of a truncated NS1 modified live influenza virus vaccine in swine. Vaccine 2007, 25:7999-8009.
24. Vincent A.L., Lager K.M., Ma W., Lekcharoensuk P., Gramer M.R., Loiacono C., et al. Evaluation of hemagglutinin subtype 1 swine influenza viruses from the United States. Vet Microbiol 2006, 118:212-222.
25. Vander Veen R., Kamrud K., Mogler M., Loynachan A.T., McVicker J., Berglund P., et al. Rapid development of an efficacious swine vaccine for novel H1N1. PLoS Curr Influenza 2009, 29:RRN1123.
26. Pena L., Vincent A.L., Ye J., Ciacci-Zanella J.R., Angel M., Lorusso A., et al. Modifications in the polymerase genes of a swine-like triple-reassortant influenza virus to generate live attenuated vaccines against 2009 pandemic H1N1 viruses. J Virol 2011, 85:456-469.
27. Perez J.T., Pham A.M., Lorini M.H., Chua M.A., Steel J., tenOever B.R. MicroRNA-mediated species-specific attenuation of influenza A virus. Nat Biotechnol 2009, 27:572-576.